Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, abrocitinib, ACA, adalimumab, AFFLIATED, AIA, Alexandre, Allergan, alopecia, amiselimod, amortised, Ankura, annualised, areata, argued, ATM, atypical, authentication, azathioprine, Bioniz, Bolsa, Bristol, CD, coercion, Colorado, CPRA, crisaborole, crohn, CSU, dominant, dominated, dry, EAE, eblasakimab, EEA, email, encryption, EoE, eosinophilic, Extortion, eye, farudodstat, female, filgotinib, Galderma, Gazette, Gilead, goodwill, Guaranty, hematopoietic, HepaRG, hoping, IBD, ID, immunosuppressive, inadvisable, incapacity, infliximab, Inline, Integrin, intermittently, ITT, JAK, Journal, Kaouhkov, Kaoukhov, Kyungnam, LGBTQ, living, Madrid, mast, matrix, maximise, mesalamine, methotrexate, minimise, mitochondrial, Mitsubishi, Moscow, NaN, natalizumab, notably, oEblasakimab, online, orchestrated, ozanimod, PDPA, perpetrated, PIPEDA, plaque, PN, POEM, prurigo, pursusant, readout, realised, recital, repair, revalued, scarring, solvency, spam, stroke, summarised, Tanabe, till, tissue, TNF, transmit, UC, ulcerative, uncommitted, underrepresented, unrestricted, upadacitinib, urticaria, ustekinumab, vedolizumab, Virginia, vitiligo, workplace
Removed:
airway, Alnair, amortized, annualized, approach, BioVeda, Bioventure, bronchial, BV, catastrophic, Cenova, chemotherapy, collection, Colombia, conjunction, conventional, COPD, coughing, Cuscaden, deductible, diagnostic, dispositive, divestment, divisional, electrical, entrance, Eucrisa, expertise, gained, Gao, heading, hospitalization, House, HPL, Iceland, inseverable, integrating, intermediate, Judge, lessee, Likewise, Macau, manager, Nanyang, nil, Northern, NTU, Nucala, obstructive, PDMA, permanent, perpetual, portrayal, pose, prophylactic, pulmonary, realization, recepteur, recognizing, resign, resistant, reverse, Road, RON, round, seniority, sensitizing, subjective, subscription, supported, taxing, technicality, telecommunication, undisclosed, vulnerable, wheezing, Wu, Xolair
Filing tables
Filing exhibits
ASLN similar filings
Filing view
External links
Exhibit 15.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-234405, 333-252575 and 333-254768 on Form F-3 and Registration Statement No. 333-252118 on Form S-8 of our report dated April 16, 2020, relating to the consolidated financial statements of ASLAN Pharmaceuticals Limited appearing in the Annual Report on Form 20-F for the year ended December 31, 2021.
/s/ Deloitte & Touche
Deloitte & Touche
Taipei, Taiwan
Republic of China
March 25, 2022